Page last updated: 2024-08-23

oxcarbazepine and Channelopathies

oxcarbazepine has been researched along with Channelopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Casasnovas, C; Castellano, A; Fons, C; Fourcade, S; Pujol, A; Ruiz, M; Schlüter, A; Verdura, E	1

Other Studies

1 other study(ies) available for oxcarbazepine and Channelopathies

Article	Year
Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia. Journal of medical genetics, 2020, Volume: 57, Issue:2 Topics: Ataxia; Channelopathies; Child; Child, Preschool; Dyskinesias; Epilepsy; Exome Sequencing; Female; Gene Expression Regulation; Homozygote; Humans; Infant; Infant, Newborn; Kv1.1 Potassium Channel; Male; Mutation; Myokymia; Oxcarbazepine; Pedigree	2020

Article

Year

Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia.

Journal of medical genetics, 2020, Volume: 57, Issue:2

Topics: Ataxia; Channelopathies; Child; Child, Preschool; Dyskinesias; Epilepsy; Exome Sequencing; Female; Gene Expression Regulation; Homozygote; Humans; Infant; Infant, Newborn; Kv1.1 Potassium Channel; Male; Mutation; Myokymia; Oxcarbazepine; Pedigree

2020